Table 2.
Multinomial regression analysis of predictors of documented recent contraception use among females aged 18–30 (N=197), matching age.
| LARC OR (95% CI) | Short-acting methods OR (95% CI) | Tubal ligation OR (95% CI) | Condoms | None | |
|---|---|---|---|---|---|
| HIV positive | 0.59 (0.15–2.41) |
1.18 (0.33–4.26) |
2.25 (0.53–9.63) |
14.1
(2.44–81.19) a |
Reference outcome |
| Participant gravida | 1.05 (0.76–1.44) |
0.93 (0.69–1.25) |
1.40
(1.01–1.94) a |
0.44
(0.23–0.85) a |
Reference outcome |
| Number of living children | 1.16 (0.70–1.90) |
1.10 (0.68–1.78) |
2.23
(1.25–3.98) a |
0.55 (0.23–1.30) |
Reference outcome |
| Mental illness history | 0.43 (0.13–1.39) |
0.49 (0.17–1.46) |
0.99 (0.27–3.63) |
3.14 (0.75–13.18) |
Reference outcome |
IUD and implant are combined as LARC.
This is an unadjusted model. The following factors were not significant and were not included in the table: history of STIs, hypertension, obesity and abnormal uterine bleeding. Short-acting methods include combined pills, progesterone-only pills, patches, rings and injected progesterone.
a
95% CI for OR excludes 1.